tirzepatide by lilly Eli weight loss drug data released Eli Lilly, Walmart Announce Expansion

Approval: 2022 Tirzepatide Once Weekly for the Treatment of Obesity (June 04, 2022) Aerobic Exercise and Weight Loss in Adults: A Systematic Review and Dose-Response Meta Analysis Update on the Effects of Physical Activity on Insulin Sensitivity in Humans (March 01, 2017) Increasing Muscle Mass to Improve Metabolism (April 01, 2013) US CDC Adult Activity: An Overview (December 20, 2023) Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (December 11, 2023)

Focus on non-scale victories: energy levels, sleep quality, how clothes fit, strength in the gym, blood work improvements, reduced joint pain

There were no cases of severe hypoglycemia reported in the trial

They sit at the center of a $100 billion-plus market projected by the end of the decade

Already at 10mg and expecting to go higher